Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: September 13, 2001
Last updated: February 1, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2007
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)